Premal Lulla, MD, assistant professor of medicine at the Center for Cell and Gene Therapy, Texas Children's Hospital, discusses the need for cellular therapies for patients with leukemia after transplant.

Patients who relapse posttransplant have a very poor prognosis, says Lulla. In this setting, there are no approved treatment options in the frontline setting.

Lulla believes the posttransplant environment has room for immunotherapy to improve outcomes. 

2019 Transplantation and Cellular Therapy Meetings

Videos

Premal Lulla, MD, discusses the need for cellular therapies for patients with leukemia after transplant.

Premal Lulla, MD

Articles

Dr. Lulla Discusses Post-Transplant Options for Leukemias